About this trial
The BALANCE study is a prospective Patient Reported Outcomes Measures (PROMs) study developed to look at the quality of life (QoL) of patients diagnosed with prostate cancer (PCa) in communities underrepresented in research, especially Black men of African, and Caribbean ancestry as well as men of Mixed ethnicity. This study will also investigate various PCa treatment types and their mental health impact on patients. There is a lack of research on PROMs in diverse populations. Collecting PROMs specifically from Black men and individuals with prostates who are receiving/have received treatment for PCa is essential for understanding their unique post-treatment experiences. The insights are vital to addressing documented disparities, tailoring supportive care and ultimately providing equitable health outcomes.
Participants in this study will be asked to complete a questionnaire (either electronically or hardcopy) to share their insights following their PCa diagnosis.
Eligibility criteria
Qualifiers
Age ≥ 18 years;
Black African ancestry; OR
Black African-Caribbean ancestry; OR
Mixed Black ancestry.
Disqualifiers
Participants having no diagnosis of PCa;
Participants unable to provide consent;
Participants assigned female at birth.
Trial design
Treatments tested in this trial
- Patient Reported Outcome Measurements (PROMs)
Treatment groups
Locations
Sponsors and collaborators
Institute of Cancer Research, United Kingdom
Lead sponsor
Royal Marsden NHS Foundation Trust
Collaborator
European Association of Urology
Collaborator